-
Aberg JA, Gallant JE, Ghanem KG, Emmanuel P, Zingman BS, Horberg MA, 2014: Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV medicine association of the Infectious Diseases Society of America[J]. Clin Infect Dis, 58, e1-34. doi: 10.1093/cid/cit665
-
Adams CM, Reitz J, De Brabander JK, Feramisco JD, Li L, Brown MS, Goldstein JL, 2004: Cholesterol and 25-hydroxycholesterol inhibit activation of SREBPs by different mechanisms, both involving SCAP and Insigs[J]. J Biol Chem, 279, 52772-52780. doi: 10.1074/jbc.M410302200
-
Bernal E, Masiá M, Padilla S, Gutiérrez F, 2008: High-density lipoprotein cholesterol in HIV-infected patients: evidence for an association with HIV-1 viral load, antiretroviral therapy status, and regimen composition[J]. AIDS Patient Care STDS, 22, 569-575. doi: 10.1089/apc.2007.0186
-
Bovolenta C, Lorini AL, Mantelli B, Camorali L, Novelli F, Biswas P, Poli G, 1999: A selective defect of IFN-gamma- but not of IFN-alpha-induced JAK/STAT pathway in a subset of U937 clones prevents the antiretroviral effect of IFN-gamma against HIV-1[J]. J Immunol, 162, 323-330.
-
Brown MS, Dana SE, Goldstein JL, 1975: Cholesterol ester formation in cultured human fibroblasts. Stimulation by oxygenated sterols[J]. J Biol Chem, 250, 4025-4027.
-
Brown MS, Goldstein JL, 1997: The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor[J]. Cell, 89, 331-340. doi: 10.1016/S0092-8674(00)80213-5
-
Bruno G, Saracino A, Monno L, Angarano G, 2017: The revival of an "Old" marker: CD4/CD8 ratio[J]. AIDS Rev, 19, 81-88.
-
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X, Zhang L, 2020: Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study[J]. Lancet, 395, 507-513. doi: 10.1016/S0140-6736(20)30211-7
-
Chen Z, Peto R, Collins R, MacMahon S, Lu J, Li W, 1991: Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations[J]. BMJ, 303, 276-282. doi: 10.1136/bmj.303.6797.276
-
Churchill MJ, Deeks SG, Margolis DM, Siliciano RF, Swanstrom R, 2016: HIV reservoirs: what, where and how to target them[J]. Nat Rev Microbiol, 14, 55-60. doi: 10.1038/nrmicro.2015.5
-
Clapham P, McKnight A, Simmons G, Weiss R, 1993: Is CD4 sufficient for HIV entry? Cell surface molecules involved in HIV infection[J]. Philos Trans R Soc Lond B Biol Sci, 342, 67-73. doi: 10.1098/rstb.1993.0137
-
Cuadrado A, Pajares M, Benito C, Jiménez-Villegas J, Escoll M, Fernández-Ginés R, Garcia Yagüe AJ, Lastra D, Manda G, Rojo AI, Dinkova-Kostova AT (2020) Can Activation of NRF2 Be a Strategy against COVID-19? Trends Pharmacol Sci. https://doi.org/10.1016/j.tips.2020.07.003
-
Dang EV, McDonald JG, Russell DW, Cyster JG, 2017: Oxysterol restraint of cholesterol synthesis prevents AIM2 inflammasome activation[J]. Cell, 171, 1057-1071.e1011. doi: 10.1016/j.cell.2017.09.029
-
Diczfalusy U, Olofsson KE, Carlsson AM, Gong M, Golenbock DT, Rooyackers O, Fläring U, Björkbacka H, 2009: Marked upregulation of cholesterol 25-hydroxylase expression by lipopolysaccharide[J]. J Lipid Res, 50, 2258-2264. doi: 10.1194/jlr.M900107-JLR200
-
Doms A, Sanabria T, Hansen JN, Altan-Bonnet N, Holm GH, 2018: 25-hydroxycholesterol production by the cholesterol-25-hydroxylase interferon-stimulated gene restricts mammalian reovirus infection[J]. J Virol, 92, e01047-18.
-
Ference BA, Ginsberg HN, Graham I, Ray KK, Packard CJ, Bruckert E, Hegele RA, Krauss RM, Raal FJ, Schunkert H, Watts GF, Borén J, Fazio S, Horton JD, Masana L, Nicholls SJ, Nordestgaard BG, van de Sluis B, Taskinen MR, Tokgözoglu L, Landmesser U, Laufs U, Wiklund O, Stock JK, Chapman MJ, Catapano AL, 2017: Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel[J]. Eur Heart J, 38, 2459-2472. doi: 10.1093/eurheartj/ehx144
-
Freiberg MS, Chang CC, Kuller LH, Skanderson M, Lowy E, Kraemer KL, Butt AA, Bidwell Goetz M, Leaf D, Oursler KA, Rimland D, Rodriguez Barradas M, Brown S, Gibert C, McGinnis K, Crothers K, Sico J, Crane H, Warner A, Gottlieb S, Gottdiener J, Tracy RP, Budoff M, Watson C, Armah KA, Doebler D, Bryant K, Justice AC, 2013: HIV infection and the risk of acute myocardial infarction[J]. JAMA Intern Med, 173, 614-622. doi: 10.1001/jamainternmed.2013.3728
-
Gidding SS, Rana JS, Prendergast C, McGill H, Carr JJ, Liu K, Colangelo LA, Loria CM, Lima J, Terry JG, Reis JP, McMahan CA, 2016: Pathobiological determinants of atherosclerosis in youth (PDAY) risk score in young adults predicts coronary artery and abdominal aorta calcium in middle age: The CARDIA study[J]. Circulation, 133, 139-146. doi: 10.1161/CIRCULATIONAHA.115.018042
-
Glass CK, Saijo K, 2010: Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells[J]. Nat Rev Immunol, 10, 365-376. doi: 10.1038/nri2748
-
Gold ES, Diercks AH, Podolsky I, Podyminogin RL, Askovich PS, Treuting PM, Aderem A, 2014: 25-Hydroxycholesterol acts as an amplifier of inflammatory signaling[J]. Proc Natl Acad Sci U S A, 111, 10666-10671. doi: 10.1073/pnas.1404271111
-
Grand M, Bia D, Diaz A, 2020: Cardiovascular risk assessment in people living With HIV: a systematic review and meta-analysis of real-life data[J]. Curr HIV Res, 18, 5-18. doi: 10.2174/1570162X17666191212091618
-
Hewing B, Landmesser U, 2015: LDL, HDL, VLDL, and CVD prevention: lessons from genetics?[J]. Curr Cardiol Rep, 17, 610-. doi: 10.1007/s11886-015-0610-z
-
Jiang Y, Zhou F, Tian Y, Zhang Z, Kuang R, Liu J, Han X, Hu Q, Xu J, Shang H, 2013: Higher NK cell IFN-γ production is associated with delayed HIV disease progression in LTNPs[J]. J Clin Immunol, 33, 1376-1385. doi: 10.1007/s10875-013-9930-1
-
Kimata JT, Rice AP, Wang J, 2016: Challenges and strategies for the eradication of the HIV reservoir[J]. Curr Opin Immunol, 42, 65-70. doi: 10.1016/j.coi.2016.05.015
-
Koethe JR, Lagathu C, Lake JE, Domingo P, Calmy A, Falutz J, Brown TT, Capeau J, 2020: HIV and antiretroviral therapy-related fat alterations[J]. Nat Rev Dis Primers, 6, 48-. doi: 10.1038/s41572-020-0181-1
-
Lee JI, Shin JS, Lee JE, Jung WY, Lee G, Kim MS, Park CG, Kim SJ, 2012: Reference values of hematology, chemistry, electrolytes, blood gas, coagulation time, and urinalysis in the Chinese rhesus macaques (Macaca mulatta)[J]. Xenotransplantation, 19, 244-248. doi: 10.1111/j.1399-3089.2012.00713.x
-
Lehmann JM, Kliewer SA, Moore LB, Smith-Oliver TA, Oliver BB, Su JL, Sundseth SS, Winegar DA, Blanchard DE, Spencer TA, Willson TM, 1997: Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway[J]. J Biol Chem, 272, 3137-3140. doi: 10.1074/jbc.272.6.3137
-
Li C, Deng YQ, Wang S, Ma F, Aliyari R, Huang XY, Zhang NN, Watanabe M, Dong HL, Liu P, Li XF, Ye Q, Tian M, Hong S, Fan J, Zhao H, Li L, Vishlaghi N, Buth JE, Au C, Liu Y, Lu N, Du P, Qin FX, Zhang B, Gong D, Dai X, Sun R, Novitch BG, Xu Z, Qin CF, Cheng G, 2017: 25-hydroxycholesterol protects host against zika virus infection and its associated microcephaly in a mouse model[J]. Immunity, 46, 446-456. doi: 10.1016/j.immuni.2017.02.012
-
Liu J, Li S, Liu J, Liang B, Wang X, Wang H, Li W, Tong Q, Yi J, Zhao L, Xiong L, Guo C, Tian J, Luo J, Yao J, Pang R, Shen H, Peng C, Liu T, Zhang Q, Wu J, Xu L, Lu S, Wang B, Weng Z, Han C, Zhu H, Zhou R, Zhou H, Chen X, Ye P, Zhu B, Wang L, Zhou W, He S, He Y, Jie S, Wei P, Zhang J, Lu Y, Wang W, Zhang L, Li L, Zhou F, Wang J, Dittmer U, Lu M, Hu Y, Yang D, Zheng X, 2020: Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients[J]. EBioMedicine, 55, 102763-. doi: 10.1016/j.ebiom.2020.102763
-
Liu SY, Aliyari R, Chikere K, Li G, Marsden MD, Smith JK, Pernet O, Guo H, Nusbaum R, Zack JA, Freiberg AN, Su L, Lee B, Cheng G, 2013: Interferon-inducible cholesterol-25-hydroxylase broadly inhibits viral entry by production of 25-hydroxycholesterol[J]. Immunity, 38, 92-105. doi: 10.1016/j.immuni.2012.11.005
-
Liu Y, Wei Z, Zhang Y, Ma X, Chen Y, Yu M, Ma C, Li X, Cao Y, Liu J, Han J, Yang X, Duan Y, 2018: Activation of liver X receptor plays a central role in antiviral actions of 25-hydroxycholesterol[J]. J Lipid Res, 59, 2287-2296. doi: 10.1194/jlr.M084558
-
Ludigs K, Parfenov V, Du Pasquier RA, Guarda G, 2012: Type I IFN-mediated regulation of IL-1 production in inflammatory disorders[J]. Cell Mol Life Sci, 69, 3395-3418. doi: 10.1007/s00018-012-0989-2
-
Lund EG, Kerr TA, Sakai J, Li WP, Russell DW, 1998: cDNA cloning of mouse and human cholesterol 25-hydroxylases, polytopic membrane proteins that synthesize a potent oxysterol regulator of lipid metabolism[J]. J Biol Chem, 273, 34316-34327. doi: 10.1074/jbc.273.51.34316
-
Lv L, Zhao G, Wang H, He H, 2019: Cholesterol 25-Hydroxylase inhibits bovine parainfluenza virus type 3 replication through enzyme activity-dependent and -independent ways[J]. Vet Microbiol, 239, 108456-. doi: 10.1016/j.vetmic.2019.108456
-
Maggi P, Di Biagio A, Rusconi S, Cicalini S, D'Abbraccio M, d'Ettorre G, Martinelli C, Nunnari G, Sighinolfi L, Spagnuolo V, Squillace N, 2017: Cardiovascular risk and dyslipidemia among persons living with HIV: a review[J]. BMC Infect Dis, 17, 551-. doi: 10.1186/s12879-017-2626-z
-
Maina EK, Bonney EY, Bukusi EA, Sedegah M, Lartey M, Ampofo WK, 2015: CD4+ T cell counts in initiation of antiretroviral therapy in HIV infected asymptomatic individuals; controversies and inconsistencies[J]. Immunol Lett, 168, 279-284. doi: 10.1016/j.imlet.2015.10.005
-
McGill HC Jr, McMahan CA, Gidding SS, 2008: Preventing heart disease in the 21st century: implications of the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study[J]. Circulation, 117, 1216-1227. doi: 10.1161/CIRCULATIONAHA.107.717033
-
Mussini C, Lorenzini P, Cozzi-Lepri A, Lapadula G, Marchetti G, Nicastri E, Cingolani A, Lichtner M, Antinori A, Gori A, d'Arminio Monforte A, 2015: CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study[J]. Lancet HIV, 2, e98-106. doi: 10.1016/S2352-3018(15)00006-5
-
Mutoh Y, Nishijima T, Inaba Y, Tanaka N, Kikuchi Y, Gatanaga H, Oka S, 2018: Incomplete recovery of CD4 cell count, CD4 percentage, and CD4/CD8 ratio in patients with human immunodeficiency virus infection and suppressed viremia during long-term antiretroviral therapy[J]. Clin Infect Dis, 67, 927-933. doi: 10.1093/cid/ciy176
-
Ouyang W, Zhou H, Liu C, Wang S, Han Y, Xia J, Xu F, 2018: 25-Hydroxycholesterol protects against acute lung injury via targeting MD-2[J]. J Cell Mol Med, 22, 5494-5503. doi: 10.1111/jcmm.13820
-
Pan E, Feng F, Li P, Yang Q, Ma X, Wu C, Zhao J, Yan H, Chen R, Chen L, Sun C, 2018: Immune protection of SIV challenge by PD-1 blockade during vaccination in rhesus monkeys[J]. Front Immunol, 9, 2415-. doi: 10.3389/fimmu.2018.02415
-
Papasavvas E, Azzoni L, Kossenkov AV, Dawany N, Morales KH, Fair M, Ross BN, Lynn K, Mackiewicz A, Mounzer K, Tebas P, Jacobson JM, Kostman JR, Showe L, Montaner LJ, 2019: NK response correlates with HIV decrease in pegylated IFN-α2a-treated antiretroviral therapy-suppressed subjects[J]. J Immunol, 203, 705-717. doi: 10.4049/jimmunol.1801511
-
Premeaux TA, Javandel S, Hosaka KRJ, Greene M, Therrien N, Allen IE, Corley MJ, Valcour VG, Ndhlovu LC, 2020: Associations between plasma immunomodulatory and inflammatory mediators with VACS index scores among older hiv-infected adults on antiretroviral therapy[J]. Front Immunol, 11, 1321-. doi: 10.3389/fimmu.2020.01321
-
Radhakrishnan A, Sun LP, Kwon HJ, Brown MS, Goldstein JL, 2004: Direct binding of cholesterol to the purified membrane region of SCAP: mechanism for a sterol-sensing domain[J]. Mol Cell, 15, 259-268. doi: 10.1016/j.molcel.2004.06.019
-
Reboldi A, Dang EV, McDonald JG, Liang G, Russell DW, Cyster JG, 2014: Inflammation. 25-Hydroxycholesterol suppresses interleukin-1-driven inflammation downstream of type I interferon[J]. Science, 345, 679-684.
-
Schoggins JW, Randall G, 2013: Lipids in innate antiviral defense[J]. Cell Host Microbe, 14, 379-385. doi: 10.1016/j.chom.2013.09.010
-
Shrivastava-Ranjan P, Bergeron É, Chakrabarti AK, Albariño CG, Flint M, Nichol ST, Spiropoulou CF, 2016: 25-hydroxycholesterol inhibition of lassa virus infection through aberrant GP1 Glycosylation[J]. mBio, 7, e01808-16.
-
Song Z, Zhang Q, Liu X, Bai J, Zhao Y, Wang X, Jiang P, 2017: Cholesterol 25-hydroxylase is an interferon-inducible factor that protects against porcine reproductive and respiratory syndrome virus infection[J]. Vet Microbiol, 210, 153-161. doi: 10.1016/j.vetmic.2017.09.011
-
Spann NJ, Glass CK, 2013: Sterols and oxysterols in immune cell function[J]. Nat Immunol, 14, 893-900. doi: 10.1038/ni.2681
-
Stamler J, Vaccaro O, Neaton JD, Wentworth D, 1993: Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial[J]. Diabetes Care, 16, 434-444. doi: 10.2337/diacare.16.2.434
-
Sun C, Chen Z, Tang X, Zhang Y, Feng L, Du Y, Xiao L, Liu L, Zhu W, Chen L, Zhang L, 2013: Mucosal priming with a replicating-vaccinia virus-based vaccine elicits protective immunity to simian immunodeficiency virus challenge in rhesus monkeys[J]. J Virol, 87, 5669-5677. doi: 10.1128/JVI.03247-12
-
Sun C, Zhang L, Zhang M, Liu Y, Zhong M, Ma X, Chen L, 2010: Induction of balance and breadth in the immune response is beneficial for the control of SIVmac239 replication in rhesus monkeys[J]. J Infect, 60, 371-381. doi: 10.1016/j.jinf.2010.03.005
-
UNAIDS Global HIV Statistics Data (2020). https://www.unaids.org/en/topic/data
-
Upadhyay J, Tiwari N, Ansari MN, 2020: Role of inflammatory markers in corona virus disease (COVID-19) patients: a review[J]. Exp Biol Med (maywood), 245, 1368-1375. doi: 10.1177/1535370220939477
-
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z, 2020: Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China[J]. JAMA, 323, 1061-1069. doi: 10.1001/jama.2020.1585
-
Wong JK, Hezareh M, Günthard HF, Havlir DV, Ignacio CC, Spina CA, Richman DD, 1997: Recovery of replication-competent HIV despite prolonged suppression of plasma viremia[J]. Science, 278, 1291-1295. doi: 10.1126/science.278.5341.1291
-
Wu T, Ma F, Ma X, Jia W, Pan E, Cheng G, Chen L, Sun C, 2018: Regulating Innate and Adaptive Immunity for Controlling SIV Infection by 25-Hydroxycholesterol[J]. Front Immunol, 9, 2686-. doi: 10.3389/fimmu.2018.02686
-
Yu W, Hao X, Yang F, Ma J, Zhao Y, Li Y, Wang J, Xu H, Chen L, Liu Q, Duan S, Yang Y, Huang F, He Z, 2019: Hematological and biochemical parameters for Chinese rhesus macaque[J]. PLoS ONE, 14, e0222338-. doi: 10.1371/journal.pone.0222338
-
Yuan Y, Wang Z, Tian B, Zhou M, Fu ZF, Zhao L, 2019: Cholesterol 25-hydroxylase suppresses rabies virus infection by inhibiting viral entry[J]. Arch Virol, 164, 2963-2974. doi: 10.1007/s00705-019-04415-6
-
Zhao J, Chen J, Li M, Chen M, Sun C, 2020: Multifaceted functions of CH25H and 25HC to modulate the lipid metabolism, immune responses, and broadly antiviral activities[J]. Viruses, 12, 727-. doi: 10.3390/v12070727
-
Zu S, Deng YQ, Zhou C, Li J, Li L, Chen Q, Li XF, Zhao H, Gold S, He J, Li X, Zhang C, Yang H, Cheng G, Qin CF, 2020: 25-Hydroxycholesterol is a potent SARS-CoV-2 inhibitor[J]. Cell Res, 30, 1043-1045. doi: 10.1038/s41422-020-00398-1